Jun 03, 2020
Aligos Therapeutics Appoints Lesley Ann Calhoun as Chief Financial Officer
SOUTH SAN FRANCISCO, Calif. June 3, 2020 – Aligos Therapeutics, Inc. (Aligos), a private biotechnology company focused on the development of targeted, antiviral therapies including chronic hepatitis B (CHB) and COVID-19 as well as therapeutics for NASH, today announced the appointment of Lesley Ann
Jun 02, 2020
Aligos Therapeutics to Present at the Jefferies Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif. June 2, 2020  –  Aligos Therapeutics, Inc., a private biotechnology company focused on the development of targeted, antiviral therapies including chronic hepatitis B (CHB) and COVID-19 as well as therapeutics for NASH, today announced that Lawrence Blatt, Ph.D., MBA ,
Jan 10, 2020
Aligos Therapeutics Closes $125M Series B Financing
SOUTH SAN FRANCISCO, Calif. January 10, 2020 – Aligos Therapeutics, Inc., a preclinical stage biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH) and
Displaying 11 - 19 of 19